Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - BIOJECT MEDICAL TECHNOLOGIES INC | d327175d8k.htm |
Exhibit 16
April 3, 2012
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-6561
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated April 3, 2012 of Bioject Medical Technologies, Inc. and are in agreement with the statements contained therein.
Respectfully,
/s/ Moss Adams LLP